Literature DB >> 2108111

Treatment of Branhamella catarrhalis infections.

B I Davies1, F P Maesen.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2108111     DOI： 10.1093/jac/25.1.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

Review 1.  [Progress in oral antibiotic therapy in practice].

Authors:  H E Pichler
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Cefpodoxime proxetil in the treatment of lower respiratory tract infections.

Authors:  A M Geddes
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

Review 4.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.

Authors:  W Klietmann; M Cesana; R K Rondel; J Focht
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.